𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Aminoglycoside antibiotics: synthesis of nebramine, tobramycin and 4″-epi-tobramycin

✍ Scribed by Masato Tanabe; Dennis M. Yasuda; George Detre

Book ID
104235602
Publisher
Elsevier Science
Year
1977
Tongue
French
Weight
213 KB
Volume
18
Category
Article
ISSN
0040-4039

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Colorimetric determination of gentamicin
Colorimetric determination of gentamicin, kanamycin, tobramycin, and amikacin aminoglycosides with 2,4-dinitrofluorobenzene
✍ James A. Ryan 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

The reaction of 2.4-dInitrofluorobenzcne (Sanger's rcagcnt) is used to form colored products with aminoglycoside antibiotics. Stopping the progress of the reaction with acid after a fixed time allows aqueous solubility to be maintained while discharging any color due to excess reactant. Thechoice of

Organochromium complexes - labelled amin
Organochromium complexes - labelled aminoglycoside antibiotics derived from kanamycin A and tobramycin. Synthesis, structural characterization and use as metallotracers for immunoassays.
✍ Jan Szymoniak; Bouchra El Mouatassim; Jack Besançon; Claude Moïse; Pierre Brossi 📂 Article 📅 1993 🏛 Elsevier Science 🌐 French ⚖ 570 KB

The synthesu of mctallocenrc denvatrves of amtnoglycostde antrbtotrcs. I e hnamyan A and tobramycm, 16 desertbed The oqanometatl&abelled compounds have been obtatnedfrom the reactwn between thepolyamtnodrugs and or&znochro~um esters of N-hydroxysuccuwntde The reaction proceeded seiecuvely at the 6'-

Synthesis of 5-deoxy-5-epifluoro derivat
Synthesis of 5-deoxy-5-epifluoro derivatives of arbekacin, amikacin, and 1-N-[(S)-4-amino-2-hydroxybutanoyl]tobramycin (study on structure — toxicity relationships)
✍ Tetsuo Shitara; Eijiro Umemura; Tsutomu Tsuchiya; Tomio Matsuno 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 840 KB

As part of a study on fluorination--toxicity relationships for aminoglycoside antibiotics, 5,3 '-dideoxy-5-epifluorokanamycin B (10), 5,3',4'-trideoxy-5-epifluorokanamycin B (11), I-N-[(S)-4-amino-2-hydroxybutanoyl]-5-deoxy-5-epifluorotobramycin (19), 5-deoxy-5-epifluoroarbekacin (20), and 5-deoxy-5